GLOBUS MEDICAL, INC. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Next earnings (estimated): Wed, April 1, 2026 — 29 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $826M | ↑+25.7% | $141M | ↑+430.4% | 20.5% |
| 2025-09-30 | $769M | ↑+22.9% | $119M | ↑+129.5% | 17.9% |
| 2025-06-30 | $745M | ↑+18.4% | $203M | ↑+538.7% | 10.2% |
| 2025-03-31 | $598M | ↓-1.4% | $75M | ↑+1160.3% | 16.2% |
| 2024-12-31 | $657M | ↑+6.6% | $27M | ↑+76.3% | 9.2% |
| 2024-09-30 | $626M | ↑+63.1% | $52M | ↑+5094.0% | 7.7% |
| 2024-06-30 | $630M | ↑+115.9% | $32M | ↓-45.0% | 7.9% |
| 2024-03-31 | $607M | ↑+119.3% | $-7M | ↓-114.5% | 1.3% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Revenue
$826M
↑+25.7% +$169M YoY
Net Income
$141M
↑+470.0% +$116M YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 60 quarters
margin trajectory tells the operating-leverage storyGross Margin↓-15.1pts
58.7%
Operating Margin↑+11.3pts
20.5%
Net Margin↑+13.0pts
17.0%
Go deeper
GMED Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyGMED Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics